Synthetic peptide analogs for the treatment of cancer

Details for Australian Patent Application No. 2003209671 (hide)

International Classifications

Event Publications

17 July 2003 Complete Application Filed

Priority application(s): 10/329,321 23.12.02 US

19 August 2004 Application Open to Public Inspection

Published as AU-B-2003209671

2 February 2006 Assignment before Grant

Dabur Research Foundation The application has been assigned to Dabur Pharma Ltd.

14 August 2008 Application Accepted

Published as AU-B-2003209671

5 March 2009 Standard Patent Sealed

20 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.